• US: +1-408-610-2300
  • Toll Free: +1-866-831-4085
  • Login / Register
Ursodeoxycholic Acid Market Growth, 2022 | Global Industry Report

Ursodeoxycholic Acid Market Size Analysis, Segmentation, Industry Outlook and Forecasts, 2017 - 2022

Report ID: MN17617699  |  Published: April 2018  |  No of Pages: 123
Format: Electronic (PDF)  |  Industry: Pharmaceuticals  |  Publisher: GEN CONSULTING

Global Ursodeoxycholic Acid Market is anticipated to grow at a CAGR of 7% in the forecast period owing to the developments occurring worldwide and changing demand from patients. Ursodeoxycholic acid is a steroid bile acid used for treating liver disorder. It naturally occurs in form of bile acid and is used to liquefy gallstones, which are rich in cholesterol. It also helps in improving the bile flow in primary biliary cirrhosis.

Ursodeoxycholic acid dissolves the cholesterol rich gallstones that accumulate due to cholesterol deposit. The acid helps prevent gallstone formation in patients’ body. Hence, people suffering from this disorder are driving the ursodeoxycholic acid market. Ursodeoxycholic acid also cures primary biliary cirrhosis by treating the symptoms. It slows down the spreading of the liver disorder and the bile duct.

Ursodeoxycholic acid also treats liver related symptom of cystic fibrosis, which is mostly present in children of 6-18 years of age. However, few symptoms may hamper the growth of ursodeoxycholic acid market. These symptoms comprise headache, diarrhea, hair loss, indigestion, vomiting or nausea, backache, unusual bleeding or bruising, cloudy and bloody urine, fever and cough, tarry or black stools, painful and/or frequent urination, swelling of lips, eyelids, tongue and face.

The market is categorized on the basis of product type, applications, and geography. On the basis of product type, market is divided into synthetic ursodeoxycholic acid and extraction ursodeoxycholic acid. Based on applications, market is divided into pharmacy and health products.

Geographically, market is segmented as North America, Europe, Asia Pacific, and RoW (Rest of the World). Asia Pacific is expected to hold the largest share of ursodeoxycholic acid market owing to the rise in liver diseases and rising elderly population in the region.

The key players in ursodeoxycholic acid market include ICE, Mitsubishi Tanabe Pharma, Arcelor Chemicals, Daewoong Chemical, Erregierre, Dipharma Francis, PharmaZell GmbH, Suzhou Tianlu, Grindeks, Abil Chempharma, Biotavia Labs, and Zhangshanbelling.

Market Segment:

Key Products
• Cholic Acid-based
• Chenodeoxycholic Acid-based

Key Regions
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• South America

Key Vendors
• Daewoong Bio
• Dipharma
• ICE
• PharmaZell
• Suzhou Tianlu
• Zhongshan Belling
• request free sample to get a complete list of companies

Key Questions Answered in this Report
• What will the market size be in 2022?
• What are the key factors driving the global ursodeoxycholic acid market?
• What are the challenges to market growth?
• Who are the key players in the ursodeoxycholic acid market?
• What are the market opportunities and threats faced by the key players?

What questions do you have? Get quick response from our industry experts. Request More information
Key questions answered in the report include
key questions
We also offers customization on reports based on specific client requirement.
Request for Customization

Choose License Type

Research Assistance

Ryan Manuel
Ryan Manuel

Research Support Specialist, USA

  1. Phone: +1-408-610-2300
  2. Toll Free: +1-866-831-4085
  3. Email: [email protected]
  • World's largest premium report database
  • Transparent pre & post sale customer engagement model
  • Unparalleled flexibility in terms of rendering services
  • Safe & secure web experience
  • 24*5 Research support service
  • 100% Secure Payments
  • Our Promise
  • 100% Service Assurance
  • Market Monitoring
  • Service Flexibility
  • 24X5 Care available